+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xenograft"

Dental Biomaterials Market Report 2025 - Product Thumbnail Image

Dental Biomaterials Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bone Regeneration Material Global Market Report 2025 - Product Thumbnail Image

Bone Regeneration Material Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Bioactive Dressings Global Market Report 2025 - Product Thumbnail Image

Bioactive Dressings Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
From
Bio Implants Market Report and Forecast 2025-2034 - Product Thumbnail Image

Bio Implants Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
From
From
Dental Bone Graft & Substitute Market Report 2023-2033 - Product Thumbnail Image

Dental Bone Graft & Substitute Market Report 2023-2033

  • Report
  • June 2023
  • 235 Pages
  • Global
From
From
Loading Indicator

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies. The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts. Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more